Abnormal sensitivity to glucagon and related peptides in primary adrenal Cushing's syndrome

Hormone and Metabolic Research

Volumn 46, Issue 12, 2014, Pages 876-882

  Louiset, E ^a   Duparc, C ^a   Groussin, L ^b   Gobet, F ^c   Desailloud, R ^d   Barrande, G ^e   Reznik, Y ^f   Bertherat, J ^b   Prevost G ^a,c   Lefebvre, H ^a,b,c  

^a UNIVERSITÉ DE ROUEN   (France)

^b Dept de Médecine Interne Ctr Hosp Univ Rouen Boisguillaume   (France)

^c ROUEN UNIVERSITY HOSPITAL   (France)

^d AMIENS UNIVERSITY HOSPITAL   (France)

^e Regional Hospital of Orleans   (France)

^f CAEN UNIVERSITY HOSPITAL   (France)

Author keywords

adenoma; cortisol; ectopic receptor; glucagon; hyperplasia; vasoactive intestinal peptide

Indexed keywords

GLUCAGON; GLUCAGON RECEPTOR; HYDROCORTISONE; PEPTIDE;

ADRENAL CORTEX ADENOMA; ADRENAL GLAND; ADULT; AGED; BLOOD; CUSHING SYNDROME; DRUG EFFECTS; FEMALE; HUMAN; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; KINETICS; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; SECRETION (PROCESS); YOUNG ADULT;

ADRENAL GLANDS; ADRENOCORTICAL ADENOMA; ADULT; AGED; CUSHING SYNDROME; FEMALE; GLUCAGON; HUMANS; HYDROCORTISONE; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; KINETICS; MALE; MIDDLE AGED; PEPTIDES; RECEPTORS, GLUCAGON; YOUNG ADULT;

EID: 84937562991     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0034-1384522     Document Type: Article

References (41)

1. Newell-Price J., Bertagna X., Grossman A. B., Nieman L. K. Cushing's syndrome. Lancet: 2006; 367 1605 1617
2. Stratakis C. A., Boikos S. A. Genetics of adrenal tumors associated with Cushing's syndrome: a new classification for bilateral adrenocortical hyperplasias. Nat Clin Pract Endocrinol Metab: 2007; 3 748 757
3. De Venanzi A., Alencar G. A., Bourdeau I., Fragoso MCB V., Lacroix A. Primary bilateral macronodular adrenal hyperplasia. Curr Opin Endocrinol Diabetes Obes: 2014; 21 177 184
4. Arnaldi G., Boscaro M. Adrenal incidentaloma. Best Pract Res Clin Endocrinol Metab: 2012; 26 405 419
5. Bimpaki E. I., Nesterova M., Stratakis C. A. Abnormalities of cAMP signaling are present in adrenocortical lesions associated with ACTH-independent Cushing syndrome despite the absence of mutations in known genes. Eur J Endocrinol: 2009; 161 153 161
6. Fragoso MCB V., Domenice S., Latronico A. C., Martin R. M., Pereira MA A., Zerbini MC N., Lucon A. M., Mendonca B. B. Cushing's syndrome secondary to adrenocorticotropin-independent macronodular adrenocortical hyperplasia due to activating mutations of GNAS1 gene. J Clin Endocrinol Metab: 2003; 88 2147 2151
7. Swords F. M., Baig A., Malchoff D. M., Malchoff C. D., Thorner M. O., King P. J., Hunyady L., Clark AJ L. Impaired desensitization of a mutant adrenocorticotropin receptor associated with apparent constitutive activity. Mol Endocrinol: 2002; 16 2746 2753
8. Horvath A., Bertherat J., Groussin L., Guillaud-Bataille M., Tsang K., Cazabat L., Libé R., Remmers E., René-Corail F., Faucz F. R., Clauser E., Calender A., Bertagna X., Carney J. A., Stratakis C. A. Mutations and polymorphisms in the gene encoding regulatory subunit type 1-alpha of protein kinase A (PRKAR1A): an update. Hum Mutat: 2010; 31 369 379
9. Beuschlein F., Fassnacht M., Assié G., Calebiro D., Stratakis C. A., Osswald A., Ronchi C. L., Wieland T., Sbiera S., Faucz F. R., Schaak K., Schmittfull A., Schwarzmayr T., Barreau O., Vezzosi D., Rizk-Rabin M., Zabel U., Szarek E., Salpea P., Forlino A., Vetro A., Zuffardi O., Kisker C., Diener S., Meitinger T., Lohse M. J., Reincke M., Bertherat J., Strom T. M., Allolio B. Constitutive activation of PKA catalytic subunit in adrenal Cushing's syndrome. N Engl J Med: 2014; 370 1019 1028
10. Cao Y., He M., Gao Z., Peng Y., Li Y., Li L., Zhou W., Li X., Zhong X., Lei Y., Su T., Wang H., Jiang Y., Yang L., Wei W., Yang X., Jiang X., Liu L., He J., Ye J., Wei Q., Li Y., Wang W., Wang J., Ning G. Activating Hotspot L205R Mutation in PRKACA and Adrenal Cushing's Syndrome. Science: 2014; 344 913 917
11. Goh G., Scholl U. I., Healy J. M., Choi M., Prasad M. L., Nelson-Williams C., Kuntsman J. W., Korah R., Suttorp A-C, Dietrich D., Haase M., Willenberg H. S., Stålberg P., Hellman P., Akerström G., Björklund P., Carling T., Lifton R. P. Recurrent activating mutation in PRKACA in cortisol-producing adrenal tumors. Nat Genet: 2014; 46 613 617
12. Assié G., Libé R., Espiard S., Rizk-Rabin M., Guimier A., Luscap W., Barreau O., Lefèvre L., Sibony M., Guignat L., Rodriguez S., Perlemoine K., René-Corail F., Letourneur F., Trabulsi B., Poussier A., Chabbert-Buffet N., Borson-Chazot F., Groussin L., Bertagna X., Stratakis C. A., Ragazzon B., Bertherat J. ARMC5 mutations in macronodular adrenal hyperplasia with Cushing's syndrome. N Engl J Med: 2013; 369 2105 2114
13. Lacroix A., Bourdeau I., Lampron A., Mazzuco T. L., Tremblay J., Hamet P. Aberrant G-protein coupled receptor expression in relation to adrenocortical overfunction. Clin Endocrinol (Oxf): 2010; 73 1 15
14. Lacroix A., Baldacchino V., Bourdeau I., Hamet P., Tremblay J. Cushing's syndrome variants secondary to aberrant hormone receptors. Trends Endocrinol Metab: 2004; 15 375 382
15. Lacroix A., Bolté E., Tremblay J., Dupré J., Poitras P., Fournier H., Garon J., Garrel D., Bayard F., Taillefer R. Gastric inhibitory polypeptide-dependent cortisol hypersecretion - a new cause of Cushing's syndrome. N Engl J Med: 1992; 327 974 980
16. Reznik Y., Allali-Zerah V., Chayvialle J. A., Leroyer R., Leymarie P., Travert G., Lebrethon M. C., Budi I., Balliere A. M., Mahoudeau J. Food-dependent Cushing's syndrome mediated by aberrant adrenal sensitivity to gastric inhibitory polypeptide. N Engl J Med: 1992; 327 981 986
17. Bertherat J., Contesse V., Louiset E., Barrande G., Duparc C., Groussin L., Emy P., Bertagna X., Kuhn J-M, Vaudry H., Lefebvre H. In vivo and in vitro screening for illegitimate receptors in adrenocorticotropin-independent macronodular adrenal hyperplasia causing Cushing's syndrome: identification of two cases of gonadotropin/gastric inhibitory polypeptide-dependent hypercortisolism. J Clin Endocrinol Metab: 2005; 90 1302 1310
18. Lacroix A., Tremblay J., Rousseau G., Bouvier M., Hamet P. Propranolol therapy for ectopic beta-adrenergic receptors in adrenal Cushing's syndrome. N Engl J Med: 1997; 337 1429 1434
19. Daidoh H., Morita H., Hanafusa J., Mune T., Murase H., Sato M., Shibata T., Suwa T., Ishizuka T., Yasuda K. In vivo and in vitro effects of AVP and V1a receptor antagonist on Cushing's syndrome due to ACTH-independent bilateral macronodular adrenocortical hyperplasia. Clin Endocrinol (Oxf): 1998; 49 403 409
20. Mune T., Murase H., Yamakita N., Fukuda T., Murayama M., Miura A., Suwa T., Hanafusa J., Daido H., Morita H., Yasuda K. Eutopic overexpression of vasopressin v1a receptor in adrenocorticotropin-independent macronodular adrenal hyperplasia. J Clin Endocrinol Metab: 2002; 87 5706 5713
21. Joubert M., Louiset E., Rego J-LD, Contesse V., Kong L. C., Benhaim A., Mittre H., Lefebvre H., Reznik Y. Aberrant adrenal sensitivity to vasopressin in adrenal tumours associated with subclinical or overt autonomous hypercortisolism: is this explained by an overexpression of vasopressin receptors? Clin Endocrinol (Oxf): 2008; 68 692 699
22. Reznik Y., Lefebvre H., Rohmer V., Charbonnel B., Tabarin A., Rodien P., Lecomte P., Bardet S., Coffin C., Mahoudeau J. Aberrant adrenal sensitivity to multiple ligands in unilateral incidentaloma with subclinical autonomous cortisol hypersecretion: a prospective clinical study. Clin Endocrinol (Oxf): 2004; 61 311 319
23. Contesse V., Reznik Y., Louiset E., Duparc C., Cartier D., Sicard F., Laquerriere A., Parmentier F., Kuhn J-M, Vaudry H., Lefebvre H. Abnormal sensitivity of cortisol-producing adrenocortical adenomas to serotonin: in vivo and in vitro studies. J Clin Endocrinol Metab: 2005; 90 2843 2850
24. Louiset E., Contesse V., Groussin L., Cartier D., Duparc C., Barrande G., Bertherat J., Vaudry H., Lefebvre H. Expression of serotonin7 receptor and coupling of ectopic receptors to protein kinase A and ionic currents in adrenocorticotropin-independent macronodular adrenal hyperplasia causing Cushing's syndrome. J Clin Endocrinol Metab: 2006; 91 4578 4586
25. Lefebvre H., Duparc C., Chartrel N., Jegou S., Pellerin A., Laquerriere A., Ivell R., Vaudry H., Kuhn J-M. Intraadrenal adrenocorticotropin production in a case of bilateral macronodular adrenal hyperplasia causing Cushing's syndrome. J Clin Endocrinol Metab: 2003; 88 3035 3042
26. Louiset E., Contesse V., Groussin L., Cartier D., Duparc C., Perraudin V., Bertherat J., Lefebvre H. Expression of vasopressin receptors in ACTH-independent macronodular bilateral adrenal hyperplasia causing Cushing's syndrome: molecular, immunohistochemical and pharmacological correlates. J Endocrinol: 2008; 196 1 9
27. Louiset E., Duparc C., Young J., Renouf S., Tetsi Nomigni M., Boutelet I., Libé R., Bram Z., Groussin L., Caron P., Tabarin A., Grunenberger F., Christin-Maitre S., Bertagna X., Kuhn J-M, Anouar Y., Bertherat J., Lefebvre H. Intraadrenal corticotropin in bilateral macronodular adrenal hyperplasia. N Engl J Med: 2013; 369 2115 2125
28. Christopoulos S., Bourdeau I., Lacroix A. Aberrant expression of hormone receptors in adrenal Cushing's syndrome. Pituitary: 2004; 7 225 235
29. Matsukura S., Kakita T., Sueoka S., Yoshimi H., Hirata Y., Yokota M., Fujita T. Multiple hormone receptors in the adenylate cyclase of human adrenocortical tumors. Cancer Res: 1980; 40 3768 3771
30. Libé R., Coste J., Guignat L., Tissier F., Lefebvre H., Barrande G., Ajzenberg C., Tauveron I., Clauser E., Dousset B., Bertagna X., Bertherat J., Groussin L. Aberrant cortisol regulations in bilateral macronodular adrenal hyperplasia: a frequent finding in a prospective study of 32 patients with overt or subclinical Cushing's syndrome. Eur J Endocrinol: 2010; 163 129 138
31. Sherwood N. M., Krueckl S. L., McRory J. E. The origin and function of the pituitary adenylate cyclase-activating polypeptide (PACAP)/glucagon superfamily. Endocr Rev: 2000; 21 619 670
32. Chabre O., Liakos P., Vivier J., Chaffanjon P., Labat-Moleur F., Martinie M., Bottari S. P., Bachelot I., Chambaz E. M., Defaye G., Feige J. J. Cushing's syndrome due to a gastric inhibitory polypeptide-dependent adrenal adenoma: insights into hormonal control of adrenocortical tumorigenesis. J Clin Endocrinol Metab: 1998; 83 3134 3143
33. Groussin L., Perlemoine K., Contesse V., Lefebvre H., Tabarin A., Thieblot P., Schlienger J. L., Luton J. P., Bertagna X., Bertherat J. The ectopic expression of the gastric inhibitory polypeptide receptor is frequent in adrenocorticotropin-independent bilateral macronodular adrenal hyperplasia, but rare in unilateral tumors. J Clin Endocrinol Metab: 2002; 87 1980 1985
34. Assie G., Louiset E., Sturm N., René-Corail F., Groussin L., Bertherat J., Thomas M., Lefebvre H., Feige J-J, Clauser E., Chabre O., Cherradi N. Systematic analysis of G protein-coupled receptor gene expression in adrenocorticotropin-independent macronodular adrenocortical hyperplasia identifies novel targets for pharmacological control of adrenal Cushing's syndrome. J Clin Endocrinol Metab: 2010; 95 E253 E262
35. Couvineau A., Laburthe M. The family B1 GPCR: structural aspects and interaction with accessory proteins. Curr Drug Targets: 2012; 13 103 115
36. de Miguel V., Redal M. A., Viale M. L., Kahan M., Glerean M., Beskow A., Fainstein Day P. Aberrant expression of glucagon receptors in adrenal glands of a patient with Cushing's syndrome and ACTH-independent macronodular adrenal hyperplasia. Medicina (Mex): 2010; 70 254 256
37. Mazzocchi G., Gottardo L., Aragona F., Albertin G., Nussdorfer G. G. Glucagon inhibits ACTH-stimulated cortisol secretion from dispersed human adrenocortical cells by activating unidentified receptors negatively coupled with the adenylate cyclase cascade. Horm Metab Res: 2000; 32 265 268
38. Neri G., Andreis P. G., Prayer-Galetti T., Rossi G. P., Malendowicz L. K., Nussdorfer G. G. Pituitary adenylate-cyclase activating peptide enhances aldosterone secretion of human adrenal gland: evidence for an indirect mechanism, probably involving the local release of catecholamines. J Clin Endocrinol Metab: 1996; 81 169 173
39. Conconi M. T., Spinazzi R., Nussdorfer G. G. Endogenous ligands of PACAP/VIP receptors in the autocrine-paracrine regulation of the adrenal gland. Int Rev Cytol: 2006; 249 1 51
40. Bornstein S. R., Haidan A., Ehrhart-Bornstein M. Cellular communication in the neuro-adrenocortical axis: role of vasoactive intestinal polypeptide (VIP). Endocr Res: 1996; 22 819 829
41. Chafai M., Basille M., Galas L., Rostene W., Gressens P., Vaudry H., Gonzalez B. J., Louiset E. Pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide promote the genesis of calcium currents in differentiating mouse embryonic stem cells. Neuroscience: 2011; 199 103 115